UK to lead next-generation radiotherapy research

  • Cancer Research UK

  • curated by Dawn O'Shea
  • Medical news
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

The UK is to be “transformed into a global hub for radiotherapy research” thanks to a new £56 million research network announced by Cancer Research UK this week.

The network, Cancer Research UK RadNet, is the charity’s largest ever investment in radiotherapy research. The charity says the project will accelerate the development of advanced radiotherapy techniques through world-first exploratory projects.

It will unite seven centres of excellence across the country: the Universities of Cambridge, Glasgow, Leeds, Manchester and Oxford, the Cancer Research UK City of London Centre (a partnership between UCL, Queen Mary University of London, King’s College London the Francis Crick Institute) and the Institute of Cancer Research, London in partnership with the Royal Marsden NHS Foundation Trust.

A total of £13 million has been allocated to form new research groups and fund additional PhD students in Manchester, London, and Cambridge.

The network will promote collaboration between diverse scientific fields, with a share of £4 million available to all centres for joint research projects, conferences, and secondments between locations.

“It’s been frustrating to see the UK lagging behind other countries when it comes to prioritising research into this vital treatment,” said Dr Adrian Crellin, Cancer Research UK Trustee and Former Vice-President of the Royal College of Radiologists. “Cancer Research UK’s investment will overhaul radiotherapy research in the UK to bring the next generation of treatments to patients sooner,” he said.